Pay in 4 interest-free payments of $5.76 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
STEP 5: In adults with obesity or overweight with at least one weight-related comorbidity, along with diet and exercise, Significant weight loss that lasts with Wegovy 2.4 mg 3 Co-primary end point: Mean change in body weight (%) from week 0 to week 104 3 During the trial, 13% of patients in the Wegovy arm discontinued treatment compared with 27% in the placebo arm
The spectrum and impact of metabolic dysfunction in MAFLD: a longitudinal cohort analysis of 32683 overweight and obese individuals
For both of these final limitations, the use of rich multimodal clinical data such as clinical notes to assess patient-level features driving motivation for GLP-1 use and discontinuation, as well as imaging to quantify and assess fat loss through CT scans could help shed light on the true impact of GLP-1s on body composition as well as patient profiles that are related to varying levels of treatment effect
This results in a healthier body composition when paired with lifestyle changes
Studied in the context of skin radiance and even skin tone
Note: This article is for educational purposes only and does not constitute medical advice
